Suspected levamisole intoxication in calves

References

• Abdelsalam EB, Ford EJ. The effect of induced liver, kidney and lung lesions on the toxicity of levamisole and diazinon in calves. Journal of Comparative Pathology 97, 619–27, 1987 doi: 10.1016/0021-9975(87)90073-9
   PubMed Web of Science ®Google Scholar
• Barragry T. Anthelmintics – review Part II. New Zealand Veterinary Journal 32, 191–9, 1984 doi: 10.1080/00480169.1984.35119
   PubMed Web of Science ®Google Scholar
• Berger H, Garces TR, Wang GT, Gale GO, Steller WA, Simkins KL. Anthelmintic efficacy, safety, and residue evaluation of levamisole gel formulation in cattle. American Journal of Veterinary Research 45, 162–4, 1984
   PubMed Web of Science ®Google Scholar
• Button C, Barton R, Honey P, Rickford P. Avermectin toxicity in calves and an evaluation of picrotoxin as an antidote. Australian Veterinary Journal 65, 157–8, 1988 doi: 10.1111/j.1751-0813.1988.tb14448.x
   PubMed Web of Science ®Google Scholar
• Cook WO, Osweiler GD, Hyde W, Stahr HM. Levamisole toxicosis in swine. Veterinary and Human Toxicology 27, 388–9, 1985
   PubMedGoogle Scholar
• Gartrell BD, Alley MR, Mitchell AH. Fatal levamisole toxicosis of captive kiwi (Apteryx mantelli). New Zealand Veterinary Journal 53, 84–6, 2004 doi: 10.1080/00480169.2005.36474
   Web of Science ®Google Scholar
• Geary TG, Hosking BC, Skuce PJ, von Samson-Himmelstjerna G, Maeder S, Holdsworth P, Pomroy W, Vercruysse J. World association for the advancement of veterinary parasitology (W.A.A.V.P.) guideline: anthelmintic combination products targeting nematode infections of ruminants and horses. Veterinary Parasitology 190, 306–16, 2012 doi: 10.1016/j.vetpar.2012.09.004
   Web of Science ®Google Scholar
• Hsu WH. Toxicity and drug interactions of levamisole. Journal of the American Veterinary Medical Association 176, 1166–9, 1980
   PubMed Web of Science ®Google Scholar
• Krueger D, Michel K, Allam S, Weiser T, Demir IE, Ceyhan GO, Zeller F, Schemann M. Effect of hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine. Neurogastroenterology & Motility 25, e530–e539, 2013 doi: 10.1111/nmo.12156
   Google Scholar
• *Lanusse CE, Lifschitz AL, Imperiale FA. Macrocyclic lactones: endectocide compounds. In: Riviere JE, Papich MG (eds). Veterinary Pharmacology & Therapeutics 9th Edtn. Pp 1119–44. Wiley-Blackwell, Ames, Iowa, USA, 2009
   Google Scholar
• Maddison J. Adverse drug reactions: report of the Australian Veterinary Association adverse drug reaction subcommittee, 1992. Australian Veterinary Journal 69, 288–91, 1992 doi: 10.1111/j.1751-0813.1992.tb09896.x
   PubMed Web of Science ®Google Scholar
• Martin RJ, Robertson AP. Control of nematode parasites with agents acting on neuromusculature systems: lessons for neuropeptide ligand discovery. Advances in Experimental Medicine and Biology 692, 138–54, 2010 doi: 10.1007/978-1-4419-6902-6_7
   PubMed Web of Science ®Google Scholar
• Maughan RJ, Shirreffs SM, Watson P. Exercise, heat, hydration and the brain. Journal of the American College of Nutrition 26 (Suppl 5), 604S–612S, 2007 doi: 10.1080/07315724.2007.10719666
   Google Scholar
• McKenna PB, Allan CM, Taylor MJ. The effectiveness of benzimidazole-levamisole combination drenches in the presence of resistance to both benzimidazole and levamisole anthelmintics in New Zealand sheep. New Zealand Veterinary Journal 44, 116–18, 1996 doi: 10.1080/00480169.1996.35948
   PubMed Web of Science ®Google Scholar
• Montgomery RD, Pidgeon GL. Levamisole toxicosis in a dog. Journal of the American Veterinary Medical Association 189, 684–85, 1986
   PubMed Web of Science ®Google Scholar
• *Parton KH, Bruere AN, Chambers JP. Levamisole. In: Chambers JP, Parton KH (eds). Veterinary Clinical Toxicology. Pp 250–1. VetLearn, Palmerston North, NZ, 2006
   Google Scholar
• Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood–brain barrier: structural components and function under physiologic and pathologic conditions. Journal of Neuroimmune Pharmacology 1, 223–36, 2006 doi: 10.1007/s11481-006-9025-3
   PubMed Web of Science ®Google Scholar
• *Pulliam JD, Preston JM. Safety of Ivermectin in target animals. In: Campbell WC (ed). Ivermectin and Abamectin. Pp 149–61. Springer Verlag, New York, NY, USA, 1989
   Google Scholar
• *Reinemeyer CR, Courtney CH. Antinematodal Drugs. In: Adams HR (ed). Veterinary Pharmacology and Therapeutics. Pp 955–57. Iowa State University Press, Ames, IA, USA, 2001
   Google Scholar
• *Roder JD. Classes of Toxicants: Pharmaceuticals: Antiparasiticals. In: Plumlee KH (ed). Clinical Veterinary Toxicology. Pp 302–4. Mosby, Maryland Heights, MO, USA, 2004
   Google Scholar
• Weiser T, Just S. Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cells. Neuroscience Letters 450, 258–61, 2009 doi: 10.1016/j.neulet.2008.12.004
   PubMed Web of Science ®Google Scholar